NU51PS005185
Cooperative Agreement
Overview
Grant Description
New Mexico Integrated Viral Hepatitis Surveillance and Prevention Program - New Mexico Integrated Viral Hepatitis Surveillance and Prevention Program
New Mexico Department of Health (NMDOH)
Proposal to Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis (DVH) under CDC-RFA-PS21-2103
Abstract
New Mexico has one of the highest rates of chronic Hepatitis C virus (HCV) infection in the nation. As the most common infectious disease, HCV causes significant liver disease and disability to persons across the state. The state has also experienced an outbreak of Hepatitis A in 2018 among persons experiencing homelessness and those who inject substances, centered in Albuquerque.
New Mexico has conducted comprehensive planning related to HCV for almost 20 years, with a consistent focus on engaging stakeholders, providers, and persons from communities disproportionately impacted by the disease. Planning work has evolved into the current New Mexico Hepatitis C Elimination Collaborative, which has representation from state agencies, healthcare providers, Project ECHO, tribal advocates, and other affected communities. This collaborative was strengthened in July 2019 when the National Governor's Association (NGA) hosted a learning lab on "State Strategies for Addressing Infectious Diseases Related to Substance Use". While the high rates of HCV in a largely rural and frontier state with significant healthcare professional shortage areas seem like a daunting challenge, the silver lining is that it has led New Mexico to be a leader and innovator in the response to viral hepatitis overall and HCV in particular. New Mexico is uniquely positioned to detect and respond to outbreaks of Hepatitis A and B and be among the first to eliminate HCV as a public health threat by 2030 due to decades of planning and program development.
With a strong background in program planning and implementation for hepatitis surveillance and prevention, as well as a statewide network of comprehensive harm reduction program sites, the New Mexico Department of Health (NMDOH) is perfectly positioned and prepared to implement all three components of PS21-2103 with little to no start-up time or development of new collaborative partnerships.
Component 1: The HIV and Hepatitis Epidemiology Program (HHEP) in the NMDOH Epidemiology and Response Division (ERD) will improve viral hepatitis reporting in several ways that will enhance detection of acute cases and outbreaks, while better describing the demographic profile of Hepatitis A, B, and C in the state so that surveillance data can be used for program planning and evaluation.
Component 2: The Hepatitis and Harm Reduction Program (HHRP) will continue to convene the New Mexico HCV Elimination Collaborative to complete the state's elimination plan and monitor strategies and progress towards the ambitious goal of eliminating HCV as a public health threat in the state by 2030.
Component 3: New Mexico's comprehensive harm reduction program sites offer the perfect venue for service expansion to respond to the infectious disease consequences of drug use. Services will be expanded with new sites, expanded services, and active navigation into medical care, and new relationships with probation and parole to serve individuals who might be reluctant to utilize SSP and health services.
New Mexico Department of Health (NMDOH)
Proposal to Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis (DVH) under CDC-RFA-PS21-2103
Abstract
New Mexico has one of the highest rates of chronic Hepatitis C virus (HCV) infection in the nation. As the most common infectious disease, HCV causes significant liver disease and disability to persons across the state. The state has also experienced an outbreak of Hepatitis A in 2018 among persons experiencing homelessness and those who inject substances, centered in Albuquerque.
New Mexico has conducted comprehensive planning related to HCV for almost 20 years, with a consistent focus on engaging stakeholders, providers, and persons from communities disproportionately impacted by the disease. Planning work has evolved into the current New Mexico Hepatitis C Elimination Collaborative, which has representation from state agencies, healthcare providers, Project ECHO, tribal advocates, and other affected communities. This collaborative was strengthened in July 2019 when the National Governor's Association (NGA) hosted a learning lab on "State Strategies for Addressing Infectious Diseases Related to Substance Use". While the high rates of HCV in a largely rural and frontier state with significant healthcare professional shortage areas seem like a daunting challenge, the silver lining is that it has led New Mexico to be a leader and innovator in the response to viral hepatitis overall and HCV in particular. New Mexico is uniquely positioned to detect and respond to outbreaks of Hepatitis A and B and be among the first to eliminate HCV as a public health threat by 2030 due to decades of planning and program development.
With a strong background in program planning and implementation for hepatitis surveillance and prevention, as well as a statewide network of comprehensive harm reduction program sites, the New Mexico Department of Health (NMDOH) is perfectly positioned and prepared to implement all three components of PS21-2103 with little to no start-up time or development of new collaborative partnerships.
Component 1: The HIV and Hepatitis Epidemiology Program (HHEP) in the NMDOH Epidemiology and Response Division (ERD) will improve viral hepatitis reporting in several ways that will enhance detection of acute cases and outbreaks, while better describing the demographic profile of Hepatitis A, B, and C in the state so that surveillance data can be used for program planning and evaluation.
Component 2: The Hepatitis and Harm Reduction Program (HHRP) will continue to convene the New Mexico HCV Elimination Collaborative to complete the state's elimination plan and monitor strategies and progress towards the ambitious goal of eliminating HCV as a public health threat in the state by 2030.
Component 3: New Mexico's comprehensive harm reduction program sites offer the perfect venue for service expansion to respond to the infectious disease consequences of drug use. Services will be expanded with new sites, expanded services, and active navigation into medical care, and new relationships with probation and parole to serve individuals who might be reluctant to utilize SSP and health services.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
New Mexico
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 35341% from $8,482 to $3,006,140.
New Mexico Department Of Health was awarded
New Mexico Viral Hepatitis Surveillance & Prevention Program
Cooperative Agreement NU51PS005185
worth $3,006,140
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in May 2021 with work to be completed primarily in New Mexico United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.940 HIV Prevention Activities Health Department Based.
The Cooperative Agreement was awarded through grant opportunity Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments.
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
5/1/21
Start Date
4/30/26
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU51PS005185
Additional Detail
Award ID FAIN
NU51PS005185
SAI Number
NU51PS005185-3720714180
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
E7TEBXBL17P5
Awardee CAGE
4FCY8
Performance District
NM-90
Senators
Martin Heinrich
Ben Luján
Ben Luján
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $1,188,465 | 99% |
Modified: 9/5/25